Protecting senior living residents from respiratory viruses means educating the community around them
By
Kimberly Bonvissuto
Sep 11, 2024
When it comes to increasing vaccination rates against respiratory viruses, it’s not only important to educate senior living residents about the value of vaccines; it’s also important to educate their...
RSV vaccination effective against hospitalization in patients 60 years and older
By
Haymarket Media
Sep 05, 2024
Vaccination effectiveness did not differ with inverse probability of vaccination weighting or for those aged 60 to 74 years and 75 years and older.
Fewer complications at 18 months seen with post-COVID-19 vaccination myocarditis
By
Haymarket Media
Aug 29, 2024
In contrast, post-COVID-19 myocarditis shows outcomes similar to conventional myocarditis.
RSV infection with inflammatory bowel disease ups risk for hospitalization
By
Haymarket Media
Aug 28, 2024
“Adult patients with IBD and RSV infection … may benefit from the new RSV vaccine recommended for adults aged 60 years and older,” the authors write.
FDA approves updated COVID shots for fall
Aug 22, 2024
Updated shots to shield against COVID-19 infection were approved by the US Food and Drug Administration on Thursday.
This week could bring FDA approval of fall COVID-19 vaccines
Aug 20, 2024
The approval comes much earlier than last year, when autumn shots were announced in mid-September.
Many US adults lost trust in physicians, hospitals during pandemic
Aug 06, 2024
Lower levels of trust were tied to significantly lower odds of COVID-19 and flu vaccination.
COVID-19 vaccination may increase risk for urinary tract symptoms
Aug 01, 2024
A higher proportion of those who received a single dose versus three doses had to urinate five or more times in the night.
CDC advises updated COVID vaccine for everyone over 6 months of age
Jun 28, 2024
Americans 65 and older account for two-thirds of COVID hospitalizations and 82% of in-hospital deaths, yet only about 40% of Americans in that age group were immunized with the COVID vaccines that were...
No decline in cardiovascular events seen with COVID-19 vaccine after acute coronary syndromes
Jun 03, 2024
Findings show no significant reduction in primary end point, MACE for those receiving vaccine after acute coronary syndromes